×
模态框(Modal)标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框(Modal)标题
×
导航切换
Home
About Journal
Columns
Editorial Board
Guide to Authors
Publishing Ethics
Subscribe
Contacts us
中文
Development of the first national reference substance of ritonavir as a candidate drug against COVID-19
XIONG Jing, LIU Yi, LIU Zhaoxia, LI Jie, ZHANG Caiyu, WU Xiangxiang, HE Lan
Chinese Journal of Pharmacovigilance . 2022, (
2
): 137 -141 . DOI: 10.19803/j.1672-8629.2022.02.06